BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1984603)

  • 1. Surfactant treatment of full-term newborns with respiratory failure.
    Auten RL; Notter RH; Kendig JW; Davis JM; Shapiro DL
    Pediatrics; 1991 Jan; 87(1):101-7. PubMed ID: 1984603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant therapy in full-term neonates with severe respiratory failure.
    Khammash H; Perlman M; Wojtulewicz J; Dunn M
    Pediatrics; 1993 Jul; 92(1):135-9. PubMed ID: 8516059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine surfactant in full-term neonates with adult respiratory distress syndrome-like disorders.
    Gortner L; Pohlandt F; Bartmann P
    Pediatrics; 1994 Mar; 93(3):538. PubMed ID: 8115229
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid assisted ventilation: an alternative ventilatory strategy for acute meconium aspiration injury.
    Foust R; Tran NN; Cox C; Miller TF; Greenspan JS; Wolfson MR; Shaffer TH
    Pediatr Pulmonol; 1996 May; 21(5):316-22. PubMed ID: 8726157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
    Dunn MS; Shennan AT; Zayack D; Possmayer F
    Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation for neonatal respiratory failure. A report of 50 cases.
    Moront MG; Katz NM; Keszler M; Visner MS; Hoy GR; O'Connell JJ; Cox C; Wallace RB
    J Thorac Cardiovasc Surg; 1989 May; 97(5):706-14. PubMed ID: 2709862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO.
    Kugelman A; Gangitano E; Taschuk R; Garza R; Riskin A; McEvoy C; Durand M
    J Pediatr Surg; 2005 Jul; 40(7):1082-9. PubMed ID: 16034749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome.
    Cochrane CG; Revak SD; Merritt TA; Schraufstätter IU; Hoch RC; Henderson C; Andersson S; Takamori H; Oades ZG
    Pediatr Res; 1998 Nov; 44(5):705-15. PubMed ID: 9803452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of heliox in the management of neonates with meconium aspiration syndrome.
    Szczapa T; Gadzinowski J
    Neonatology; 2011; 100(3):265-70. PubMed ID: 21701217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of respiratory failure due to respiratory syncytial virus pneumonia with natural surfactant.
    Vos GD; Rijtema MN; Blanco CE
    Pediatr Pulmonol; 1996 Dec; 22(6):412-5. PubMed ID: 9016476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].
    Silberg IE; Grønn M
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1456-8. PubMed ID: 9198922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function after surfactant lung lavage followed by surfactant administration in infants with severe meconium aspiration syndrome.
    Szymankiewicz M; Gadzinowski J; Kowalska K
    J Matern Fetal Neonatal Med; 2004 Aug; 16(2):125-30. PubMed ID: 15512724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
    Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
    Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
    Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous surfactant therapy in newborns.
    Rodriguez RJ; Martin RJ
    Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.